Elasterate

Elasterate Brand names, Elasterate Analogs

Elasterate Brand Names Mixture

No information avaliable

Elasterate Chemical_Formula

C₂₀H₂₁ClO₄

Elasterate RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Elasterate fda sheet

Elasterate FDA

Elasterate msds (material safety sheet)

Elasterate MSDS

Elasterate Synthesis Reference

No information avaliable

Elasterate Molecular Weight

360.831 g/mol

Elasterate Melting Point

80.5 °C

Elasterate H₂O Solubility

0.25mg/ml at 25 °C

Elasterate State

Solid

Elasterate LogP

5.575

Elasterate Dosage Forms

Capsule; Tablet

Elasterate Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Elasterate Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Elasterate Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Elasterate side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Elasterate Patient Information